Obesity - Recent Insights and Therapeutic Options 2023
DOI: 10.5772/intechopen.111935
|View full text |Cite
|
Sign up to set email alerts
|

Obesity: A Prerequisite for Major Chronic Illnesses

Hafeez Abiola Afolabi,
Zaidi Zakaria,
Salzihan Md. Salleh
et al.

Abstract: Obesity is rampantly soaring at an alarming rate globally and simultaneously causing an increased incidence, and predisposition to various comorbidities. obesity is body mass index of >30kg/m2, while <18kg/m2 is underweight. The world at large fails to recognize obesity as an inevitable disease that requires strict measures to control this modifiable risk factor. W.H.O news release reported that over one billion people globally are obese among which 650 million were adults, 340 million were adolescents, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 114 publications
0
1
0
Order By: Relevance
“…Obesity is highly associated with T2DM due to the increased abdominal and intra-abdominal fat distribution and increased intrahepatic and intramuscular triglyceride content that has been reported as a critical risk factor for developing T2DM, causing insulin resistance and β-cell dysfunction ( Gilyana et al, 2024 ). Interestingly, the cost of obesity-related comorbidities has been estimated at US dollars 2.0 trillion globally, indicating a major problem for healthcare systems nowadays ( Afolabi et al, 2023 ; Tremmel et al, 2017 ). Thus, the documentation of effective behavioral interventions appears to be a high priority for public health policy makers to enhance awareness of the vital role of regular exercise among the masses.…”
Section: Introductionmentioning
confidence: 99%
“…Obesity is highly associated with T2DM due to the increased abdominal and intra-abdominal fat distribution and increased intrahepatic and intramuscular triglyceride content that has been reported as a critical risk factor for developing T2DM, causing insulin resistance and β-cell dysfunction ( Gilyana et al, 2024 ). Interestingly, the cost of obesity-related comorbidities has been estimated at US dollars 2.0 trillion globally, indicating a major problem for healthcare systems nowadays ( Afolabi et al, 2023 ; Tremmel et al, 2017 ). Thus, the documentation of effective behavioral interventions appears to be a high priority for public health policy makers to enhance awareness of the vital role of regular exercise among the masses.…”
Section: Introductionmentioning
confidence: 99%